Published

A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Psychotherapy (Chicago, Ill.)
Date: 2025-09-01
Source: PubMed
DOI: 10.1037/pst0000551
PubMed: 39804360

Authors

Palitsky R Maples-Keller JL Peacock C Dunlop BW Mletzko T Grant GH Raison CL Chao S Shub I Mendelbaum-Kweller M Smolyar L Kaplan DM Rothbaum BO Zarrabi AJ

Watch author

Derived topics and classifications

psilocybin Chronic Pain Spirituality Clinical Trial Cancer Patients Healthcare Workers Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

A critical evaluation of psilocybin-assisted therapy protocol components from clinical trial patients, facilitators, and caregivers.2025-09-01

Related papers

The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.ClinicalTrials.gov · 2026-05-08 Characterization of Altered Waking States of Consciousness in Healthy HumansClinicalTrials.gov · 2021-04-29